Kodiak Sciences (KOD) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
23 Apr, 2026Executive summary
Annual meeting scheduled for June 2, 2026, to be held virtually for shareholders of record as of April 6, 2026.
Shareholders are encouraged to review proxy materials online and can request paper or email copies if desired.
Voting matters and shareholder proposals
Election of three Class II directors: Charles A. Bancroft, Bassil I. Dahiyat, Ph.D., and Taiyin Yang, Ph.D.
Advisory vote to approve named executive officer compensation.
Ratification of PricewaterhouseCoopers LLP as independent auditor for the fiscal year ending December 31, 2026.
Proxies may vote on other business that arises during the meeting.
Board of directors and corporate governance
Board recommends voting in favor of all three proposals presented at the annual meeting.
Partial view of Summaries dataset, powered by Quartr API
Latest events from Kodiak Sciences
- Net loss hit $123.8M in H1 2026; cash supports operations into 2027, but funding gap remains.KOD
Q2 2026 - Late-stage retinal therapies advance toward key data and BLA filings, targeting approvals by 2027.KOD
Jefferies Global Healthcare Conference 2026 - Q1 2026 saw a $58.2M net loss, strong Phase 3 data, and pivotal trials with funding needs ahead.KOD
Q1 2026 - Shareholders will vote on directors, executive pay, and auditor, with a focus on performance and ESG.KOD
Proxy filing - Strong clinical milestones and solid cash position support continued late-stage development.KOD
Q4 2025 - Late-stage retina therapies show strong efficacy and durability, targeting major unmet needs.KOD
Corporate presentation - Late-stage pipeline advances with enhanced ABCD platform, strong cash, and key data in 2025–26.KOD
R&D Day 2024 - Advancing three late-stage retinal programs with durable, multi-mechanism therapies and strong funding.KOD
Jefferies 2024 Global Healthcare Conference - Pivotal retinal trials advance with improved formulations and strong financial runway.KOD
Goldman Sachs 45th Annual Global Healthcare Conference